WATERS CORP /DE/
WATAPI behind this page
WAT Q1 2026 request
Playground key active
/api/financials?ticker=WAT&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 1,267 | 662 | +91.4% |
Show Product Lines breakouts |
|||
| Consumables [Member] · Transferred At Point In Time | 543 | 138 | +293.5% |
| Instrument systems [Member] · Transferred At Point In Time | 376 | 263 | +43.0% |
| Product | 919 | 401 | +129.2% |
| Service | 348 | 261 | +33.3% |
| Service · Transferred At Point In Time | 101 | 81 | +24.7% |
| Service · Transferred Over Time | 247 | 180 | +37.2% |
Show Business Segments breakouts |
|||
| Waters Advanced Diagnostics [Member] · Americas | 151 | 19 | +694.7% |
| Waters Advanced Diagnostics [Member] · Americas Other [Member] | 30 | 3 | +900.0% |
| Waters Advanced Diagnostics [Member] · Asia Other [Member] | 40 | 5 | +700.0% |
| Waters Advanced Diagnostics [Member] · Asia Pacific | 66 | 15 | +340.0% |
| Waters Advanced Diagnostics [Member] · CN | 26 | 10 | +160.0% |
| Waters Advanced Diagnostics [Member] · European Union | 132 | 19 | +594.7% |
| Waters Advanced Diagnostics [Member] · Material Reconciling Items | 349 | 53 | +558.5% |
| Waters Advanced Diagnostics [Member] · Operating Segments | 349 | 53 | +558.5% |
| Waters Advanced Diagnostics [Member] · US | 121 | 16 | +656.2% |
| Waters Analytical & Material Sciences [Member] · Americas | 246 | 237 | +3.8% |
| Waters Analytical & Material Sciences [Member] · Americas Other [Member] | 42 | 37 | +13.5% |
| Waters Analytical & Material Sciences [Member] · Asia Other [Member] | 133 | 125 | +6.4% |
| Waters Analytical & Material Sciences [Member] · Asia Pacific | 233 | 206 | +13.1% |
| Waters Analytical & Material Sciences [Member] · CN | 100 | 81 | +23.5% |
| Waters Analytical & Material Sciences [Member] · European Union | 207 | 166 | +24.7% |
| Waters Analytical & Material Sciences [Member] · Material Reconciling Items | 686 | 609 | +12.6% |
| Waters Analytical & Material Sciences [Member] · Operating Segments | 686 | 609 | +12.6% |
| Waters Analytical & Material Sciences [Member] · US | 204 | 200 | +2.0% |
| Waters Biosciences [Member] · Americas | 108 | — | — |
| Waters Biosciences [Member] · Americas Other [Member] | 18 | — | — |
| Waters Biosciences [Member] · Asia Other [Member] | 24 | — | — |
| Waters Biosciences [Member] · Asia Pacific | 51 | — | — |
| Waters Biosciences [Member] · CN | 27 | — | — |
| Waters Biosciences [Member] · European Union | 73 | — | — |
| Waters Biosciences [Member] · Material Reconciling Items | 232 | — | — |
| Waters Biosciences [Member] · Operating Segments | 232 | — | — |
| Waters Biosciences [Member] · US | 90 | — | — |
Show Geography breakouts |
|||
| Americas Other [Member] · Operating Segments | 90 | 40 | +125.0% |
| Americas · Operating Segments | 505 | 256 | +97.3% |
| Asia Other [Member] · Operating Segments | 197 | 130 | +51.5% |
| Asia Pacific · Operating Segments | 350 | 221 | +58.4% |
| CN · Operating Segments | 153 | 91 | +68.1% |
| European Union · Operating Segments | 412 | 185 | +122.7% |
| US · Operating Segments | 415 | 216 | +92.1% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 1,267 | 662 | +91.4% |
| Operating Segments | 1,267 | 662 | +91.4% |
Show Timing Of Transfer Of Good Or Service breakouts |
|||
| Transferred At Point In Time | 1,020 | 482 | +111.6% |
| Transferred Over Time | 1,267 | 662 | +91.4% |
| Cost of Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 524 | 169 | +210.1% |
| Service | 155 | 108 | +43.5% |
| Selling, General & Administrative | 387 | 174 | +122.4% |
| Research & Development | 96 | 47 | +104.3% |
| Amortization Of Acquisition Costs | 152 | 12 | +1166.7% |
| Total Costs & Expenses | 1,314 | 510 | +157.6% |
| Operating Income | -47 | 152 | -130.9% |
Show Business Segments breakouts |
|||
| Waters Advanced Diagnostics [Member] · Material Reconciling Items | 70 | 20 | +250.0% |
| Waters Analytical & Material Sciences [Member] · Material Reconciling Items | 236 | 215 | +9.8% |
| Waters Biosciences [Member] · Material Reconciling Items | 83 | — | — |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -47 | 151 | -131.1% |
| Other Non-Operating Income (Expense) | 1 | 1 | 0.0% |
| Interest Expense | -48 | -14 | -242.9% |
| Interest Income | 6 | 4 | +50.0% |
| Income Before Taxes | -88 | 143 | -161.5% |
| Income Tax Expense (Benefit) | 16 | -22 | +172.7% |
| Net Income | -72 | 121 | -159.5% |
Show Equity Components breakouts |
|||
| Retained Earnings | -72 | 121 | -159.5% |
| EPS (Basic) | -0.87 | 2.04 | -142.6% |
| Wtd Avg Shares (Basic) | 82,139 | 59,439 | +38.2% |
| EPS (Diluted) | -0.87 | 2.03 | -142.9% |
| Wtd Avg Shares (Diluted) | 82,139 | 59,711 | +37.6% |
| Revenue | 1,267 | 662 | +91.4% |
Show Product Lines breakouts |
|||
| Consumables [Member] | 543 | 138 | +293.5% |
| Instrument systems [Member] | 376 | 263 | +43.0% |
| Service | 348 | 261 | +33.3% |
| Comprehensive Income | -115 | 127 | -190.6% |
| Other Comprehensive Income | -43 | 6 | -816.7% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | -5 | — | — |
| Accumulated Other Comprehensive Income | -43 | — | — |
| Accumulated Translation Adjustment | -38 | — | — |
| Labor And Related Expense (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Waters Advanced Diagnostics [Member] · Material Reconciling Items | -50 | — | — |
| Waters Analytical & Material Sciences [Member] · Material Reconciling Items | -159 | — | — |
| Waters Biosciences [Member] · Material Reconciling Items | -34 | — | — |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -243 | — | — |
| Other Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Waters Advanced Diagnostics [Member] · Material Reconciling Items | -132 | -11 | -1100.0% |
| Waters Analytical & Material Sciences [Member] · Material Reconciling Items | -44 | -146 | +69.9% |
| Waters Biosciences [Member] · Material Reconciling Items | -53 | — | — |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -229 | -157 | -45.9% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 462 | 382,872 | -99.9% |
Show Legal Entity breakouts |
|||
| Held By Foreign Subsidiaries [Member] | 425 | 287 | +48.1% |
Show Investment Type breakouts |
|||
| Held In Currencies Other Than Us Dollars [Member] | 321 | 226 | +42.0% |
| Accounts Receivable | 1,753 | — | — |
Show Business Acquisition breakouts |
|||
| BDS Business [Member] | 415 | — | — |
| Inventory | 1,496 | 511,499 | -99.7% |
| Other Assets Current | 353 | 132,234 | -99.7% |
| Total Current Assets | 4,064 | 1,739,883 | -99.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,520 | 643,260 | -99.8% |
| Goodwill | 9,317 | — | — |
Show Business Segments breakouts |
|||
| Waters Advanced Diagnostics [Member] | 3,373 | — | — |
| Waters Analytical & Material Sciences [Member] | 2,107 | — | — |
| Waters Biosciences [Member] | 3,837 | — | — |
| Operating Lease Right-of-Use Assets | 356 | — | — |
Show Property Plant And Equipment By Type breakouts |
|||
| Automobiles One [Member] | 35 | — | — |
| Property Plant And Equipment Other Types | 36 | — | — |
| Other Non-Current Assets | 498 | 269,876 | -99.8% |
| Total Assets | 24,531 | 4,591,576 | -99.5% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 8,776 | 560,754 | -98.4% |
| Current Liabilities | |||
| Notes Payable Current | 360 | 100,000 | -99.6% |
| Accounts Payable | 602 | — | — |
Show Business Acquisition breakouts |
|||
| BDS Business [Member] | 275 | — | — |
| Employee Related Liabilities Current | 196 | 60,875 | -99.7% |
| Revenue Remaining Performance Obligation | 520 | 340,086 | -99.8% |
| Operating Lease Liability Current | 53 | — | — |
Show Balance Sheet Location breakouts |
|||
| Operating Lease Liabilities, Acquired [Member] | 24 | — | — |
| Other Current Liabilities | 29 | — | — |
| Accrued Income Taxes Current | 47 | 172,868 | -100.0% |
| Standard Product Warranty Accrual Current | 22 | 12 | +83.3% |
| Other Liabilities Current | 473 | 145,798 | -99.7% |
| Total Current Liabilities | 2,273 | 960,969 | -99.8% |
| Debt Current (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Senior Unsecured Notes Series K [Member] | 160 | 160,000 | -99.9% |
| Senior Unsecured Notes Series L [Member] | 200 | 200,000 | -99.9% |
| Senior Unsecured Notes Series M [Member] | 300 | 300,000 | -99.9% |
| Non-Current Liabilities | |||
| Long-Term Debt | 4,855 | 1,356,727 | -99.6% |
Show Debt Instrument breakouts |
|||
| Fixed Interest Rate [Member] · Unsecured Debt | 4.6 | 1.3 | +253.8% |
Show Long-Term Debt Type breakouts |
|||
| Unsecured Debt | 1.1 | 1.3 | -15.4% |
| Long Term Deferred Tax Liabilities | 1,568 | — | — |
| Operating Lease Liabilities | 302 | — | — |
Show Balance Sheet Location breakouts |
|||
| Operating Lease Liabilities, Acquired [Member] | 259 | — | — |
| Other Noncurrent Liabilities | 43 | — | — |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 57 | 44,380 | -99.9% |
| Accrued Income Taxes Noncurrent | 28 | 32,729 | -99.9% |
| Other Non-Current Liabilities | 156 | 182,126 | -99.9% |
| Liabilities Noncurrent | 6,966 | 1,668,210 | -99.6% |
| Total Liabilities | 9,239 | 2,629,179 | -99.6% |
| Contract With Customer Liability Noncurrent (Q) | — | — | — |
Show Balance Sheet Location breakouts |
|||
| Other Noncurrent Liabilities | 103 | 81 | +27.2% |
| Stockholders' Equity | |||
| Common Stock | 2 | — | — |
| Additional Paid In Capital Common Stock | 15,273 | 2,362,309 | -99.4% |
| Retained Earnings | 10,359 | 9,910,036 | -99.9% |
| Treasury Stock Value | -10,174 | -10,161,727 | +99.9% |
| Accumulated Other Comprehensive Income | -168 | -149,852 | +99.9% |
| Total Stockholders' Equity | 15,292 | 1,962 | +679.4% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 2 | -236 | +100.8% |
| Accumulated Net Unrealized Investment Gain Loss | -7 | -1,244 | +99.4% |
| Accumulated Other Comprehensive Income | -168 | -150 | -12.0% |
| Accumulated Translation Adjustment | -163 | -148,372 | +99.9% |
| Additional Paid In Capital | 15,273 | 2,362 | +546.6% |
| Common Stock | 2 | 2 | 0.0% |
| Retained Earnings | 10,359 | 9,910 | +4.5% |
| Treasury Stock Common | -10,174 | -10,162 | -0.1% |
| Total Liabilities & Equity | 24,531 | 4,591,576 | -99.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -72 | 121 | -159.5% |
| Stock-Based Compensation | 20 | 13 | +53.8% |
| Deferred Income Taxes | -1 | 2 | -150.0% |
| Depreciation | 36 | 22 | +63.6% |
| Adjustment For Amortization | 171 | 28 | +510.7% |
| Acquisition Related Inventory And Fixed Assets Fair Value Step Ups Recognized | 99 | — | — |
| Change in Accounts Receivable | -533 | 33 | -1715.2% |
| Change in Inventory | -33 | -26 | -26.9% |
| Change in Prepaid & Other Assets | -98 | — | — |
| Increase Decrease In Other Operating Assets | 174 | 13 | +1238.5% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 235 | -30 | +883.3% |
| Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination | 138 | 83 | +66.3% |
| Increase Decrease In Other Operating Liabilities | -139 | 1 | -14000.0% |
| Net Cash from Operations | -3 | 260 | -101.2% |
| Investing Activities | |||
| Payments To Acquire Productive Assets | -39 | -26 | -50.0% |
| Cash Acquired From Acquisition | 144 | — | — |
| Proceeds Payments Of Equity Investments | -10 | — | — |
| Net Cash from Investing | 95 | -26 | +465.4% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 3,530 | — | — |
Show Credit Facility breakouts |
|||
| Credit Agreement [Member] | 3.5 | — | — |
| Repayments Of Long Term Debt | -3,700 | -170 | -2076.5% |
Show Credit Facility breakouts |
|||
| Credit Agreement [Member] | -3.7 | — | — |
| Debt Issuance Costs | -25 | — | — |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 3 | 8 | -62.5% |
| Share Repurchases | -12 | -14 | +14.3% |
| Payments For Proceeds From Derivative Instrument Financing Activities | -9 | 2 | -550.0% |
| Net Cash from Financing | -213 | -173 | -23.1% |
| Supplemental | |||
| Stock Issued1 | 12,835 | — | — |
| Change In Deposit Asset | 42 | — | — |
| Notes Payable And Debt Assumed | 4,000 | — | — |
| Estimated Net Working Capital Adjustment | 121 | — | — |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -5 | -3 | -66.7% |
| Net Change in Cash | -126 | 58 | -317.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 462 | 383 | +20.6% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.